Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

IDX/CARE stock hub

IDX/CARE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/CAREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.8T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/CARE

In the news

Latest news · IDX/CARE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E403.5

P25 11.5P50 23.8P75 52.6

ROE1.1

P25 0.6P50 5.1P75 12.2

ROIC2.7

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/CARE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

IDR

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	881
Employees Change	70%
Employees Change Percent	8.63
Enterprise value	IDR 14.4T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	ID1000154909
Last refreshed	2026-05-10
Market cap	IDR 13.8T
Price	IDR 414
Price currency	IDR
Rev Per Employee	548,158,804.27x
Sector	Healthcare
Sic	8060
Symbol	idx/CARE
Website	https://www.metrohealthcareindonesia.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.25%
EV Earnings	421.12x
EV/EBIT	133.96x
EV/EBITDA	107.2x
EV/FCF	-115.72x
EV/Sales	29.75x
FCF yield	-0.9%
P/B ratio	4.55x
P/E ratio	403.48x
P/S ratio	28.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.21%
EBITDA Margin	27.75%
Gross margin	52.16%
Gross Profit	IDR 251.9B
Gross Profit Growth	150.21%
Gross Profit Growth Q	155.97%
Gross Profit Growth3 Y	42.89%
Gross Profit Growth5 Y	16.95%
Net Income	IDR 34.1B
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth5 Y	6.56%
Pretax Margin	7.78%
Profit Margin	7.06%
Profit Per Employee	IDR 38.7M
Profitable Years	1
ROA	1.64
Roa5y	-0.12
ROCE	3.01
ROE	1.15
Roe5y	-1.73
ROIC	2.71
Roic5y	-0.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	95.37%
Cagr3y	-3.73%
Cagr5y	5.69%
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth5 Y	4.05
OCF Growth5 Y	17.12%
Revenue Growth	53.22x
Revenue Growth Q	56.04x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	24.25x
Revenue Growth5 Y	15.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.12
Assets	IDR 4.2T
Cash	IDR 472.3B
Current Assets	IDR 515.8B
Current Liabilities	IDR 615.6B
Debt	IDR 1.1T
Debt EBITDA	IDR 8
Debt Equity	IDR 0.35
Debt FCF	IDR -8.64
Equity	IDR 3T
Interest Coverage	1.27
Liabilities	IDR 1.1T
Long Term Assets	IDR 3.7T
Long Term Liabilities	IDR 533.9B
Net Cash	IDR -599.9B
Net Cash By Market Cap	IDR -4.36
Net Debt EBITDA	IDR 4.48
Net Debt Equity	IDR 0.2
Tangible Book Value	IDR 3T
Tangible Book Value Per Share	IDR 90.89
WACC	2.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.84
Inventory Turnover	39.29
Net Working Capital	IDR -25.9B
Quick ratio	0.82
Working Capital	IDR -99.8B
Working Capital Turnover	IDR -2.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	95.28%
200-day SMA	391.4
3Y total return	-10.78%
50-day SMA	420.5
50-day SMA vs 200-day SMA	50over200
5Y total return	31.85%
All Time High	965
All Time High Change	-57.1%
All Time High Date	2026-01-23
All Time Low	56
All Time Low Change	639.29%
All Time Low Date	2024-06-03
ATR	15.53
Beta	-0.46
Beta1y	-0.17
Beta2y	0.06
Ch YTD	-39.12
High	448
High52	965
High52 Date	2026-01-23
High52ch	-57.1%
Low	406
Low52	208
Low52 Date	2025-05-08
Low52ch	104.95%
Ma50ch	-1.54%
Price vs 200-day SMA	5.79%
RSI	46.18
RSI Monthly	56.12
RSI Weekly	49.48
Sharpe ratio	1.24x
Sortino ratio	2.13
Total Return	-1.28%
Tr YTD	-39.12
Tr1m	0.49%
Tr1w	0.98%
Tr3m	-8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 107.3B
Operating margin	22.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,650,000,001%
Net Borrowing	142,905,992,990
Shares Institutions	17.32%
Shares Out	33,250,000,000
Shares Qo Q	5.78%
Shares Yo Y	1.28%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -124.2B
Average Volume	879,540x
Bv Per Share	90.89
CAPEX	IDR -208.4B
Ch1m	0.49
Ch1w	0.98
Ch1y	95.28
Ch3m	-8
Ch3y	-10.78
Ch5y	31.85
Ch6m	26.22
Change	0.98%
Change From Open	-0.96
Close	410
Days Gap	1.95
Depreciation Amortization	26,777,223,924
Dollar Volume	959,569,200
Earnings Date	2026-05-13
EBIT	IDR 107.3B
EBITDA	IDR 134B
EPS	IDR 1.01
F Score	7
FCF	IDR -124.2B
FCF EV Yield	-0.86x
FCF Per Share	IDR -3.73
Financing CF	146,388,453,720
Fiscal Year End	December
Founded	2,015
Graham Number	45.4993
Graham Upside	-89.01
Income Tax	IDR 3.1B
Investing CF	-258,878,608,381
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2026-03-31
Lynch Fair Value	IDR 6.64
Lynch Upside	-98.4
Ma150	434.8
Ma150ch	-4.78%
Ma20	414
Ma20ch	0%
Net CF	-28,213,544,591
Next Earnings Date	2026-05-13
Open	418
P OCF Ratio	163.3
Position In Range	19.05
Ppne	3,268,421,631,022
Price Date	2026-05-08
Price EBITDA	IDR 103
Ptbv Ratio	4.55
Relative Volume	2.94x
Revenue	482,927,906,563x
Tax By Revenue	0.65x
Tax Rate	8.32%
Tr6m	26.22%
Volume	2,317,800

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/CARE pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/CARE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/CARE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.3%

Negative means the company is buying back shares.

Technical

IDX/CARE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.2

Neutral momentum band

Price vs 200-day MA

+5.8%

50/200-day relationship not available

Beta (5Y)

-0.46

Less volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/CARE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/CARE stock rating?

idx/CARE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/CARE analysis?

The full report lives at /stocks/idx/CARE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/CARE?

The latest report frames idx/CARE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/CARE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.